Alkami Technology, Inc. SEC Filings

Alex Shootman, Alkami Technology's Chief Executive Officer and a director, reported a sale of 42,930 shares of Alkami common stock at $25.66 per share to satisfy tax withholding obligations tied to the vesting and settlement of restricted stock units (RSUs). After the reported sale the reporting person beneficially owned 796,563 shares. The Form 4 states the transaction was a "sell to cover" to fund tax withholding and was not a discretionary sale by the reporting person.

Prerna Sachdeva, Chief Accounting Officer of Alkami Technology, Inc. (ALKT), reported a routine insider sale on a Form 4. The filing shows a disposition of 2,967 shares of Alkami common stock on 09/02/2025 at a price of $24.76 per share. The sale was executed as a "sell-to-cover" to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units. Following the transaction, the reporting person beneficially owns 66,061 shares. The Form 4 was signed by an attorney-in-fact and filed with the SEC.

Douglas A. Linebarger, Chief Legal Officer of Alkami Technology, Inc. (ALKT), reported a non-discretionary sale of 8,242 shares of common stock on 09/02/2025 at a price of $24.76 per share. The filing states the shares were sold to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs) and were executed as a "sell to cover" rather than a voluntary trade. After the transaction the reporting person beneficially owned 229,930 shares directly. The Form 4 was signed on 09/04/2025 and was filed by one reporting person.

W. Bryan Hill, Chief Financial Officer and director of Alkami Technology, Inc. (ALKT), reported the sale of 20,366 shares of the company's common stock on 09/02/2025 at a price of $24.76 per share. The filing shows the transaction was a "sell-to-cover" to satisfy tax withholding on vested RSUs and was not a discretionary sale by the reporting person. After the transaction, the reporting person beneficially owned 409,889 shares. The Form 4 discloses standard insider reporting details and clarifies the sale's purpose as tax-related rather than an open-market liquidity decision.

Alex Shootman, Chief Executive Officer and a director of Alkami Technology, Inc. (ALKT), reported a sale of 75,000 shares of common stock on 08/27/2025, at a weighted-average price of $25.1954 per share (individual trade prices ranged from $24.84 to $25.36). After the reported sale, the reporting person beneficially owned 839,493 shares. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan, and the filer offers to provide details on the number of shares sold at each price within the reported range upon request.

General Atlantic and affiliated funds filed a Schedule 13D reporting shared beneficial ownership of 12,033,436 shares of Alkami Technology, Inc. common stock, representing 11.6% of the class based on 104,083,138 shares outstanding as of June 30, 2025. This Schedule 13D amends and supersedes a previously filed Schedule 13G/A.

The filing states the shares were acquired for investment purposes. The Reporting Persons may engage with shareholders, management or the board and may buy, sell or otherwise change their position over time. Purchases during the 60-day period before August 20, 2025 are reported in an attached Annex A. The group entered a Joint Filing Agreement and discloses shared voting and dispositive power over the reported shares.

General Atlantic-affiliated investment vehicles reported a sequence of open-market purchases of Alkami Technology (ALKT) common stock between August 11 and August 13, 2025. The group acquired a total of 1,396,162 shares across five transactions at net prices ranging from $20.647 to $22.5388. These purchases increased the reporting group's combined beneficial ownership to 12,033,436 shares.

The filings identify multiple General Atlantic entities as reporting persons, each marked as a director and a 10% owner for Section 16 purposes, and include descriptive footnotes explaining the ownership structure and group relationships. No derivative securities were reported on this Form 4.

General Atlantic and affiliated funds increased their beneficial ownership in Alkami Technology through multiple open-market purchases. The Form 4 reports acquisitions on 08/11/2025 and 08/13/2025 totaling 1,396,162 shares bought at net prices ranging from $20.647 to $22.5388 per share (individual lots: 250,000; 400,000; 516,771; 100,000; 129,391). After these transactions the filing shows aggregate beneficial ownership of 12,033,436 shares, consisting of 9,645,318 shares held by General Atlantic (AL), 2,346,162 held by GA AL Holding and employee-held amounts including 34,731 shares and 7,225 RSUs. The report lists multiple affiliated funds and states they may be deemed a group while disclaiming ownership beyond direct holdings.

Alkami Technology's Form 3 shows that General Atlantic GenPar (Bermuda), L.P. and affiliated General Atlantic entities beneficially own 10,637,274 shares of Alkami common stock, reported as indirect holdings. The filing discloses 9,645,318 shares held by General Atlantic (AL), L.P., 950,000 shares held by General Atlantic Partners (Bermuda) T, L.P., plus 34,731 shares and 7,225 restricted stock units held for an employee. No derivative securities are reported and the filing describes a multi-entity group ownership structure with customary disclaimers.